Macrophage signaling in HIV-1 infection

Department of Virology, UPRES 4266 Pathogens and Inflammation, IFR 133 INSERM, University of Franche-Comté, CHU Besançon, F-25030 Besançon, France.
Retrovirology (Impact Factor: 4.77). 04/2010; 7:34. DOI: 10.1186/1742-4690-7-34
Source: PubMed

ABSTRACT The human immunodeficiency virus-1 (HIV-1) is a member of the lentivirus genus. The virus does not rely exclusively on the host cell machinery, but also on viral proteins that act as molecular switches during the viral life cycle which play significant functions in viral pathogenesis, notably by modulating cell signaling. The role of HIV-1 proteins (Nef, Tat, Vpr, and gp120) in modulating macrophage signaling has been recently unveiled. Accessory, regulatory, and structural HIV-1 proteins interact with signaling pathways in infected macrophages. In addition, exogenous Nef, Tat, Vpr, and gp120 proteins have been detected in the serum of HIV-1 infected patients. Possibly, these proteins are released by infected/apoptotic cells. Exogenous accessory regulatory HIV-1 proteins are able to enter macrophages and modulate cellular machineries including those that affect viral transcription. Furthermore HIV-1 proteins, e.g., gp120, may exert their effects by interacting with cell surface membrane receptors, especially chemokine co-receptors. By activating the signaling pathways such as NF-kappaB, MAP kinase (MAPK) and JAK/STAT, HIV-1 proteins promote viral replication by stimulating transcription from the long terminal repeat (LTR) in infected macrophages; they are also involved in macrophage-mediated bystander T cell apoptosis. The role of HIV-1 proteins in the modulation of macrophage signaling will be discussed in regard to the formation of viral reservoirs and macrophage-mediated T cell apoptosis during HIV-1 infection.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human immunodeficiency virus type 1 (HIV-1) establishes latency in resting memory CD4+ T cells and cells of myeloid lineage. In contrast to the T cells, cells of myeloid lineage are resistant to the HIV-1 induced cytopathic effect. Cells of myeloid lineage including macrophages are present in anatomical sanctuaries making them a difficult drug target. In addition, the long life span of macrophages as compared to the CD4+ T cells make them important viral reservoirs in infected individuals especially in the late stage of viral infection where CD4+ T cells are largely depleted. In the past decade, HIV-1 persistence in resting CD4+ T cells has gained considerable attention. It is currently believed that rebound viremia following cessation of combination anti-retroviral therapy (cART) originates from this source. However, the clinical relevance of this reservoir has been questioned. It is suggested that the resting CD4+ T cells are only one source of residual viremia and other viral reservoirs such as tissue macrophages should be seriously considered. In the present review we will discuss how macrophages contribute to the development of long-lived latent reservoirs and how macrophages can be used as a therapeutic target in eradicating latent reservoir.
    Viruses 03/2015; 7(4):1578-1598. DOI:10.3390/v7041578 · 3.28 Impact Factor
  • Source
    Current Perspectives in HIV Infection, Edited by Shailendra K. Saxena, 04/2013: chapter 1; InTech., ISBN: ISBN 978-953-51-1057-6
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Redox signaling plays a crucial role in the pathogenesis of Human Immunodeficiency Virus type-1 (HIV-1). Majority of HIV redox research relies on measuring redox stress using invasive technologies, which are unreliable and do not inform the contributions of sub-cellular compartments. A major technological leap emerges from the development of genetically encoded redox sensitive green fluorescent proteins (roGFPs), which provide sensitive and compartment-specific insights into redox homeostasis. Here, we exploited a roGFP based specific bioprobe of glutathione redox potential (EGSH; Grx1-roGFP2) and measured sub-cellular changes in EGSH during various phases of HIV-1 infection using U1 monocytic cells (latently infected U937 cells with HIV-1). We show that while U937 and U1 cells demonstrate significantly reduced cytosolic and mitochondrial EGSH (≈ −310 mV), active viral replication induces substantial oxidative stress (EGSH > −240 mV). Furthermore, exposure to a physiologically-relevant oxidant, hydrogen peroxide (H2O2) induces significant deviations in sub-cellular EGSH between U937 and U1, which distinctly modulates susceptibility to apoptosis. Using Grx1-roGFP2, we demonstrate that a marginal increase of about ~25 mV in EGSH is sufficient to switch HIV-1 from latency to reactivation, raising the possibility of purging HIV-1 by redox modulators without triggering detrimental changes in cellular physiology. Importantly, we show that bioactive lipids synthesized by clinical drug resistant isolates of Mycobacterium tuberculosis (Mtb) reactivate HIV-1 through modulation of intracellular EGSH. Finally, the expression analysis of U1 and patient Peripheral Blood Mononuclear Cells (PBMCs) demonstrated a major recalibration of cellular redox homeostatic pathways during persistence and active replication of HIV.
    Journal of Biological Chemistry 11/2014; 290(2). DOI:10.1074/jbc.M114.588913 · 4.60 Impact Factor

Full-text (4 Sources)

Available from
Jun 4, 2014